Hydrophobic residues at position 10 of α-conotoxin PnIA influence subtype selectivity between α7 and α3β2 neuronal nicotinic acetylcholine receptors

被引:24
|
作者
Hopping, Gene [1 ]
Wang, C-I Anderson [1 ]
Hogg, Ron C. [2 ]
Nevin, Simon T. [3 ]
Lewis, Richard J. [1 ]
Adams, David J. [3 ,4 ]
Alewood, Paul F. [1 ]
机构
[1] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia
[2] Ctr Med Univ Geneva, Fac Med, Dept Neurosci, CH-1211 Geneva 4, Switzerland
[3] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia
[4] RMIT Univ, Hlth Innovat Res Inst, Bundoora, Vic 3083, Australia
基金
澳大利亚国家健康与医学研究理事会; 澳大利亚研究理事会;
关键词
Nicotinic acetylcholine receptors; Alpha-conotoxin; Structure-function relationship; PHASE PEPTIDE-SYNTHESIS; CRYSTAL-STRUCTURE; BIOLOGICAL-ACTIVITY; ALZHEIMERS-DISEASE; BINDING PROTEIN; HOMOLOG ACHBP; SUBUNIT; CHANNEL; TARGETS; NACHR;
D O I
10.1016/j.bcp.2014.07.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuronal nicotinic acetylcholine receptors (nAChRs) are a diverse class of ligand-gated ion channels involved in neurological conditions such as neuropathic pain and Alzheimer's disease. alpha-Conotoxin [A10L]PnIA is a potent and selective antagonist of the mammalian alpha 7 nAChR with a key binding interaction at position 10. We now describe a molecular analysis of the receptor-ligand interactions that determine the role of position 10 in determining potency and selectivity for the alpha 7 and alpha 3 beta 2 nAChR subtypes. Using electrophysiological and radioligand binding methods on a suite of [A10L]PnIA analogs we observed that hydrophobic residues in position 10 maintained potency at both subtypes whereas charged or polar residues abolished alpha 7 binding. Molecular docking revealed dominant hydrophobic interactions with several alpha 7 and alpha 3 beta 2 receptor residues via a hydrophobic funnel. Incorporation of norleucine (Nle) caused the largest (8-fold) increase in affinity for the alpha 7 subtype (Ki = 44 nM) though selectivity reverted to alpha 3 beta 2 (IC50 = 0.7 nM). It appears that the placement of a single methyl group determines selectivity between alpha 7 and alpha 3 beta 2 nAChRs via different molecular determinants. Crown Copyright (C) 2014 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:534 / 542
页数:9
相关论文
共 50 条
  • [41] Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine α3β2 receptors
    Wu, Tse-Yu
    Smith, Caleb M.
    Sine, Steven M.
    Levandoski, Mark M.
    MOLECULAR PHARMACOLOGY, 2008, 74 (02) : 466 - 475
  • [42] Animal models with mutations in the α7 and β2 subunits and in the β4, α3, α5 cluster of neuronal nicotinic acetylcholine receptors.
    Orr-Urtreger, A
    Xu, W
    Saeki, M
    Goldner, F
    Sutcliffe, CB
    Lorenzo, I
    Goldberg, L
    Armstrong, DL
    De Biasi, M
    Dani, JA
    Patrick, J
    Beaudet, AL
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A9 - A9
  • [43] Subtype-specific actions of β-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (α7, α4β2, α3β4) expressed in Xenopus laevis oocytes
    Pym, L
    Kemp, M
    Raymond-Delpech, V
    Buckingham, S
    Boyd, CAR
    Sattelle, D
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (07) : 964 - 971
  • [44] α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors
    Wu, Yong
    Zhangsun, Dongting
    Zhu, Xiaopeng
    Kaas, Quentin
    Zhangsun, Manqi
    Harvey, Peta J.
    Craik, David J.
    McIntosh, J. Michael
    Luo, Sulan
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5826 - 5833
  • [45] STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL α-CONOTOXIN BT1.8 FROM CONUS BETULINUS SELECTIVELY TARGETING NEURONAL α6/α3β2β3 AND α3β2 NICOTINIC ACETYLCHOLINE RECEPTORS
    Ning, Huying
    Huang, Biling
    Liu, Zhuguo
    Li, Liang
    Zhang, Longxiao
    Guo, Chenyun
    Dai, Qiuyun
    TOXICON, 2019, 158 : S68 - S68
  • [46] A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors
    Luo, Sulan
    Zhangsun, Dongting
    Schroeder, Christina I.
    Zhu, Xiaopeng
    Hu, Yuanyan
    Wu, Yong
    Weltzin, Maegan M.
    Eberhard, Spencer
    Kaas, Quentin
    Craik, David J.
    McIntosh, J. Michael
    Whiteaker, Paul
    FASEB JOURNAL, 2014, 28 (04): : 1842 - 1853
  • [47] Methadone is a Non-Competitive Antagonist at the α4β2 and α3*Nicotinic Acetylcholine Receptors and an Agonist at the α7 Nicotinic Acetylcholine Receptor
    Talka, Reeta
    Salminen, Outi
    Tuominen, Raimo K.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 116 (04) : 321 - 328
  • [48] A molecular link between inward rectification and calcium permeability of neuronal nicotinic acetylcholine α3β4 and α4β2 receptors
    Haghighi, AP
    Cooper, E
    JOURNAL OF NEUROSCIENCE, 2000, 20 (02): : 529 - 541
  • [49] alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected
    Flood, P
    RamirezLatorre, J
    Role, L
    ANESTHESIOLOGY, 1997, 86 (04) : 859 - 865
  • [50] Nicotine-morphine interactions at α4β2, α7 and α3* nicotinic acetylcholine receptors
    Talka, Reeta
    Salminen, Outi
    Whiteaker, Paul
    Lukas, Ronald J.
    Tuominen, Raimo K.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 701 (1-3) : 57 - 64